Review Article

Classification of proteins expression in some popular cancers for protein biomarkers identification

ali farid , kazem Porbadakhshan

ali farid
. Email:

kazem Porbadakhshan

Online First: December 29, 2017 | Cite this Article
farid, a., Porbadakhshan, k. 2017. Classification of proteins expression in some popular cancers for protein biomarkers identification. The Cancer Press 3(4). DOI:10.15562/tcp.59

Recognition of the source and stage of cancer has always been one of the Issues of interest to scientists. On the other hand, cancer is the second leading cause of death worldwide after cardiovascular disease. According to the Global Burden of Disease Cancer Report In 2015, there were 17.5 million cancer cases worldwide and over 8.7 million cancer deaths. Based on the same report, breast cancer, TBL (tracheal, bronchus, and lung) cancer and colorectal cancer were the most common incidents. From another perspective, one of the requirements for the treatment of different cancers is early diagnosis in the early stages. With the end of the human genome project, molecular medicine moved to a step beyond the genome called "proteomics". Proteomic ideas play an important role in discovering cancer biomarkers for early diagnosis of disease, prediction and prognosis, identifying new drug goals, monitoring the effectiveness of treatment and personal therapy. Nowadays with new developments in mass spectrometry and bioinformatics, new biomarkers can be identified for different cancers. To analyze a cancer, identifying only one biomarker does not provide enough information for that cancer, but paying attention to changes in the level of expression of various proteins is valuable. In this paper, effective proteins for breast, lung and colorectal cancers, have been identified and classified. Biomarkers sparse in different articles are combined using Text Mining and reviewing articles that introduced a cancer biomarker. In fact, by examining changes in the expression of proteins in the cancerous tissue and considering their significant changes, they are referred to as cancer marker candidates for early diagnosis or even prediction of future illness. This research offers text mining algorithms to collect cancer biomarker's.


Zamanian-Azodi M, Rezaie-Tavirani M, Heydari-Kashal S, Kalantari S, Dailian S, Zali H. "Proteomics analysis of MKN45 cell line before and after treatment with Lavender aqueous extract". Gastroenterol Hepatol Bed Bench. 2012;5(1):35-42.

Zali H, Rezaei-Tavirani M, Azodi M. Gastric, "cancer: prevention, risk factors and treatment",Gastroenterol Hepatol Bed bench. 2011;4(4):175-85.

Fitzmaurice C, Dicker D, Pain A, Hamavid H, Moradi-Lakeh M, MacIntyre MF, et al. "The global burden of cancer",JAMA oncology. 2015;1(4):505-27.

Karin D. Rodland,"Proteomics and cancer diagnosis: the potential of mass spectrometry", Clinical Biochemistry 37 (2004) 579–583.

Hayat MA, "Methods of cancer diagnosis therapy and prognosis: liver cancer",1th:ed Springer Verlag. 2009.P.14

Pooladi M, Sobhi S, Abad SK, Hashemi M, Moradi A, Zali AR, et al. "The Investigation of Heat Shock Protein (HSP70) Expression Change in Human Brain Asterocytoma Tumor", Iran J Cancer Prevent. 2013;6:6-11.

Rozek W, Ciborowski PS, "Proteomics and Genomics Neuroimmune Pharmacology",2thed,Springer; 2008.P.725-41.

Gottfries J, Sjögren M, Holmberg B, Rosengren L, Davidsson P, Blennow K. "Proteomics for drug target discovery", Chemom Intell Lab Sys. 2004;73:47-53.

Scarano EM, Fiorita AN, Picciotti PM, Passali GC, Calo L, Cabras T, et al. "Proteomics of saliva:personal experience", Acta Otorhinolaryngol Ital. 2010;30:125.

Simon J, Andrew R. "Proteome Bioinformatics", Methods in Molecular Biology, vol. 604:2010.

Bichsel VE, Liotta LA. "Cancer proteomics: from biomarker discovery to signal pathway profiling", Cancer J. 2001;7(1):69-78.

Clarke W, Zhang Z, Chan DW. "The Application of Clinical Proteomics to Cancer and other Diseases", Clin Chem Lab Med. 2003;41(12):1562–70.

Borchers C, Chen T, Neamati N. "Application of Proteomics in Basic Biological Sciences and Cancer", Molecular Carcinogenesis and the Molecular Biology of Human Cancer,chapter12,26pages.

Ardekani AM, Liotta LA, Petricoin EF. "Clinical potential of proteomics in the diagnosis of ovarian cancer". Expert Rev Mol Diagn. 2002;2(4):312-20.

Maes E, Mertens I, Valkenborg D, Pauwels P, Rolfo C, Baggerman G. "Proteomics In cancer research:Are We ready for clinical practice? ", 2015;96(3):437-48.

Krüger T, Lautenschläger J, Grosskreutz J, Rhode H. "Proteome analysis of body fluids for amyotrophic lateral sclerosis biomarker discovery", Proteomics Clin Appl. 2013;7(1-2):123-35.

Robert Grützmann,"Application of Proteomics in Cancer Biomarker DiscoveryCancer,Gene Profiling: Methods and Protocols", Methods in Molecular Biology, vol. 1381.

Leth-Larsen R, Lund RR, Ditzel HJ. "Plasma membrane proteomics and its application in clinical cancer biomarker discovery", Mol Cell Proteom 2010;9:1369-82.

Honda K, Ono M, Shitashige M, Masuda M, Kamita M, Miura N, et al. "Proteomic approaches to the discovery of cancer biomarkers for early detection and personalized medicine",Japan J Clin Oncol. 2013;43:103-9.

Wulfkuhle JD, Liotta LA, Petricoin EF,"Proteomic applications for the early detection of cancer", Nat Rev Cancer. 2003;3:267-75.

Ludwig JA, Weinstein JN. "Biomarkers in cancer staging, prognosis and treatment selection", Nat Rev Cancer. 2005;5:845-56.

Srinivas PR, Verma M, Zhao Y, Srivastava S. "Proteomics for cancer biomarker discovery". Clin Chem. 2002;48:1160-9.

Phan JH. "Biomarker discovery and clinical outcome prediction using knowledge based bioinformatics", Georgia Institute of Technology Emory University May 2009

Chaerkady R, Pandey A. "Quantitative proteomic for identification of cancer biomarkers", Proteomics Clin Appl. 2007;1(9):1080-9.

Srinivas PR, Kramer BS, Srivastava S, "Trends in biomarker research for cancer detection. Lancet Oncol", 2001;2(11):698-12.

Safaei A, Rezaei-Tavirani M, Sobhi S, Akbari ME. "Breast Cancer Biomarker Discovery: Proteomics and Genomics Approaches", Iran J Cancer Prevent. 2013;6:45-53

Rezaei-Tavirani M, Zali H, Jazii FR, Heidari MH, Hoseinzadeh-Salavati B, Daneshi-Mehr F, et al. "Introducing aldolase C as a differentiation biomarker:A proteomics approach", J Para med Sci 2010;1.33-39

Carol E. Parker, Christoph H. Borchers,"Mass spectrometry based biomarker discovery, verification, and validation e Quality assurance and control of protein biomarker assays",molecular oncology 8(2014)840-858

Cohen, K. Bretonnel; Hunter, Lawrence, "Getting Started in Text Mining", PLoS Comput Biol. 2008 Jan;4(1):e20.

Jenssen TK, Lægreid A, Komorowski J, Hovig E,"A literature network of human genes for high-throughput analysis of gene expression", Nat Genet. 2001;28(1):21.

Masys DR. "Linking microarray data to the literature", Nat Genet. 2001;28(1):9.

Zhu F, Patumcharoenpol P, Zhang C, Yang Y, Chan J, Meechai A, et al. "Biomedical text mining and its applications in cancer research", J Biomed Inform. 2013;46(2):200-11.

Li H, Liu C. "Biomarker Identification Using Text Mining" 2012;2012:135780.

Fang YC, Huang HC, Juan HF,"MeInfoText: associated gene methylation and cancer information from text mining", BMC Bioinformatics. 2008;9(1):22.

Fang YC, Lai PT, Dai HJ, Hsu WL," MeInfoText 2.0: gene methylation and cancer relation extraction from biomedical literature", BMC Bioinformatics. 2011;12(1):471.

Ongenaert M, Van Neste L, De Meyer T, Menschaert G, Bekaert S, Van Criekinge W, "PubMeth: a cancer methylation database combining textmining and expert annotation", Nucleic Acids Res. 2008;36:D842–6.

Deng X, Geng H, Bastola DR, Ali HH. "Link test – a statistical method for finding prostate cancer biomarkers", Comput Biol Chem. 2006;30:425–33.

Natarajan J, Berrar D, Dubitzky W, Hack C, Zhang Y, DeSesa C, et al. "Text mining of full-text journal articles combined with gene expression analysis reveals a relationship between sphingosine-1-phosphate and invasiveness of a glioblastoma cell line", BMC Bioinformatics 2006;7:373.

Krallinger M, Leitner F, Valencia A,"Analysis of biological processes and diseases using text mining approaches", Methods Mol Biol. 2010;593:341–82.

Korhonen A, Silins I, Sun L, Stenius U,"The first step in the development of TextMining technology for Cancer Risk Assessment: identifying and organizing scientific evidence in risk assessment literature", BMC Bioinformatics. 2009;10:303.

Guo Y, Korhonen A, Liakata M, Silins I, Hogberg J, Stenius U. A "comparison and user-based evaluation of models of textual information structure in the context of cancer risk assessment", BMC Bioinformatics. 2011;12:69.

Abacha AB, Zweigenbaum P,"Automatic extraction of semantic relations between medical entities: a rule based approach", J Biomed Semantics. 2011;2(Suppl. 5):S4.

Lee CH, Wu CH, Yang HC. "Text mining of clinical records for cancer diagnosis", Second international conference on innovative computing, informatio and control: IEEE computer society; 2007.

Pucci-Minafra I, Di Cara G, Musso R, Cancemi P, Albanese NN, Roz E, et al. "Retrospective Proteomic Screening of 100 Breast Cancer Tissues", Proteomes. 2017;5(3):15.

Ramsey B, Bai T, Newell AH, Troxell M, Park B, Olson S, et al. "GRB7 protein over-expression and clinical outcome in breast cancer", Breast Cancer Res Treat. 2011;127(3):659-69.

Minden A. "The Pak4 Protein Kinase in Breast Cancer", ISRN Oncol. ,2012;2012:694201.

Newman L, Xia W, Yang HY, Sahin A, Bondy M, Lukmanji F, et al. "Correlation of p27 Protein Expression With HER-2/neu Expression in Breast Cancer", Mol Carcinog. 2001;30(3):169-75.

Slamon DJ, Clark GM, Wong SG, Levin WJ, Ullrich A, McGuire WL. "Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu", oncogene Science. 1987;235(4785):177-82.

Porter PL, Malone KE, Heagerty PJ, Alexander GM, Gatti LA, Firpo EJ, et al. "Expression of cell-cycle regulators p27Kip1 and cyclin E,alone and in combination,correlate with survival in young breast cancer patients", Nat Med. 1997;3:222-5

Kheirandish S, Homaee F. "Ki67 protein:a proliferation index in breast cancer", Rev Clin Med. 2015;2(4):201-4.

Zahra Madjd et al,"BRCA1 Protein Expression Level and CD44+ Phenotype in Breast Cancer Patients",Cell Journal (Yakhteh), Vol 13, No 3, Autumn 2011,155-162

Xu H, Liu C, Zhao Z, Gao N, Chen G, Wang Y, et al. "Clinical implications of GRHL3 protein expression in breast cancer", Tumor Biol. 2014,35:1827-31

Calaf GM, Echiburú-Chau C, Zhao YL, Hei TK, "BigH3 protein expression as a marker for breast cancer", Int J Mol Med. 2008;21(5):561-8.

Meiqun C, Zifan G, Kehuan S, Zhengzhi W," Application of iTRAQ Quantitative Proteomics in Identification of Serum Biomarkers in breast cancer", 2011 4th International Conference on Biomedical Engineering and Informatics,978-1-4244-9352-2011 IEEE

Asch HL, Head K, Dong Y, Natoli F, Winston JS, Connolly JL, et al. "Widespread loss of gelsolin in breast cancers of humans, mice, and rats" Cancer Res. 1996;56(21):4841-5.

Koren R, Dekel Y, Sherman E, Weissman Y, Dreznik Z, Klein B, et al. "The expression of DCC protein in female breast cancer. Breast Cancer" Res Treat. 2003;80(2):215-20.

Jeong HC, Kim GI, Cho SH, Lee KH, Ko JJ, Yang JH, et al. "Proteomic Analysis of Human Small Cell Lung Cancer Tissues:Up-Regulation of Coactosin-Like Protein-1", J Proteome Res. 2011;10(1):269-76.

Mehan MR, Ayers D, Thirstrup D, Xiong W, Ostroff RM, Brody EN, et al. "Protein Signature of Lung Cancer Tissues", PLoS ONE PloS one. 2012;7(4):e35157.

Knizhnik AV, Kovaleva OV, Laktionov KK, Mochalnikova VV, Komelkov AV, Tchevkina EM, et al. "Arf6,RalA and BIRC5 Protein Expression in Nonsmall Cell Lung Cancer", Mol Biol (Mosk). 2011;45(2):307-15.

Hung JJ, Hsueh CT, Chen KH, Hsu WH, Wu YC,"Clinical significance of E2F1 protein expression in non-small cell lung cancer", Exp Hematol Oncol. 2012,1:18

Motadi LR, Bhoola KD, Dlamini Z. "Expression and function of retinoblastoma binding protein 6(RBBP6)in human lung cancer", Immunobiology. 2011;216(10):1065-73.

Zhong H, Qian Y, Fang S, Yang L, Li L, Gu W. "HE4 expression in lung cancer,a meta-analysis", Clinica Chimica Acta. 2017;470:109-14.

Yang GC, Fu BC, Zhang DY, Sun L, Chen W, Bai L, et al. "The Expression and Related Clinical Significance of SIRT3 in NSCLC", Dis Markers. 2017;2017:8241953.

Liang JF, Wang HK, Xiao H, Li N, Cheng CX, Zhao YZ, et al. "Research Relationship and prognostic significance of SPARC and VEGF protein expression in colon cancer", J Exp Clin Cancer Res. 2010;29:71.

Berney CR, Fisher RJ, Yang JL, Russell PJ, Crowe PJ. "Protein Markers in Colorectal Cancer: Predictors of Liver Metastasis", Ann Surg. 1999;230(2):179-84.

Fallahnezhad S, Nikbakht M, Shokri S. "Expression of P33ing1b Protein in Colorectal Cancer", Middle East J Dig Dis. 2016;8(1):44-50.

Horimoto M, Resnick MB, Konkin TA, Routhier J, Wands JR, Baffy G. "Expression of Uncoupling Protein-2 in Human Colon Cancer", Clin Cancer Res. 2004;10(18):6203-7.

Liu H, Kong Q, Li B, He Y, Li P, Jia B. "Expression of PEBP4 protein correlates with the invasion and metastasis of colorectal cancer",Tumor Biol. 2012;33(1):267-73.

Wu J, Wang G, He B, Chen X, An Y. "Methylation of the UNC5C gene and its protein expression in colorectal cancer", Tumor Biol. 2017;39(4):1010428317697564.

Dimberg J, Hugander A, Wagsater D. "Protein expression of the chemokine,CCL28,in human colorectal cancer", Int J Oncol. 2006;28(2):315-9.

Koshiyama A, Ichibangase T, Imai K. "Comprehensive fl orogenic derivatization liquid chromatography/tandem mass spectrometry proteomic analysis of colorectal cancer cell to identify biomarker candidate", Biomed Chromatogr. 2013;27:440-50

Article Views      : 41
PDF Downloads : 12